Literature DB >> 10526977

Reduction of apoptosis of in vitro cultured lymphocytes of HIV-positive persons by N(G)-hydroxy-methylated-L-arginine and 1'-methyl-ascorbigen.

J Bocsi1, K Nagy, E Tyihák, L Trézl, B Szende.   

Abstract

Some formaldehyde generating chemicals due to reduction of apoptosis in lymphocytes may slow down the progress of immune decline of HIV-infected individuals. N(G)-hydroxy-methylated-L-arginine (MAX) and 1'-methyl-ascorbigen (MeAsc) could enter this way the biochemical pathway of cells and affect the apoptotic process. Separated peripheral blood lymphocytes of five asymptomatic HIV-positive persons were cultured. Unstimulated, IL-2 stimulated and IL-2 stimulated plus 0.1, 1.0, 10.0 microg/ml MAX or MeAsc treated lymphocytes were investigated for apoptosis morphologically (HE) and by flow cytometrical DNA fragmentation method. IL-2 stimulation lowered the apoptotic rate in lymphocytes of HIV-positive persons related to unstimulated ones. MAX and MeAsc reduced the apoptotic activity of stimulated lymphocytes in the least or the middle doses while in the higher dose did not. MAX and MeAsc reduced the apoptotic activity of stimulated lymphocytes originated from HIV-positive patients in vitro. This compounds may have the same effect in vivo and may prolong the symptomless period of HIV-infected patients. The role of methylation and production of formaldehyde in this process is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10526977

Source DB:  PubMed          Journal:  Acta Biol Hung        ISSN: 0236-5383


  2 in total

1.  The Interrelationship of Pharmacologic Ascorbate Induced Cell Death and Ferroptosis.

Authors:  Tamás Lőrincz; Marianna Holczer; Orsolya Kapuy; András Szarka
Journal:  Pathol Oncol Res       Date:  2018-11-15       Impact factor: 3.201

Review 2.  Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators.

Authors:  Naroa Kajarabille; Gladys O Latunde-Dada
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.